CIK 0000874015 · Large accelerated filer
IONIS PHARMACEUTICALS INC
Sign in to watch- Ticker
- IONS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- CA
- Entity type
- operating
- EIN
- 330336973
- Phone
- 7609319200
- Business address
- 2855 GAZELLE COURT, CARLSBAD, CA, 92010
- Former names
- ISIS PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $148,200
- in 1 filing
- Open-market sales, last 90 days
- $61,389
- in 2 filings
Net +$86,811. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-01 | Hayden Michael R Director | Grant or award · Restricted Stock Unit | +2,301 | 12,198 | ||
| 2026-07-01 | Diaz Allene M. Director | Grant or award · Non-Qualified Stock Option (right to buy) | +5,369 | 5,369 | ||
| 2026-07-01 | Diaz Allene M. Director | Grant or award · Restricted Stock Unit | +2,301 | 7,521 | ||
| 2026-07-01 | BERTHELSEN SPENCER R Director | Grant or award · Non-Qualified Stock Option (right to buy) | +5,369 | 5,369 | ||
| 2026-07-01 | BERTHELSEN SPENCER R Director | Grant or award · Restricted Stock Unit | +2,301 | 7,521 | ||
| 2026-06-26 | Baroldi Joseph EVP, Chief Business Officer | Option exercise 10b5-1 | +3,866 | $56.78 | $220K | 8,535 |
| 2026-06-26 | Baroldi Joseph EVP, Chief Business Officer | Option exercise 10b5-1 | +1,769 | $32.60 | $58K | 10,304 |
| 2026-06-26 | Baroldi Joseph EVP, Chief Business Officer | Sale 10b5-1 | −5,635 | $80.16 | $452K | 4,669 |
| 2026-06-26 | Baroldi Joseph EVP, Chief Business Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −1,769 | 0 | ||
| 2026-06-26 | Baroldi Joseph EVP, Chief Business Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −3,866 | 0 | ||
| 2026-06-26 | O'NEIL PATRICK R. EVP CLO & General Counsel | Sale 10b5-1 | −3,069 | $80.00 | $246K | 61,470 |
| 2026-06-26 | Schneider Eugene EVP, Chf Clinical Develop Ofcr | Option exercise 10b5-1 | +26,000 | $60.89 | $1.6M | 103,114 |
| 2026-06-26 | Schneider Eugene EVP, Chf Clinical Develop Ofcr | Sale 10b5-1 | −26,000 | $81.05 | $2.1M | 77,114 |
| 2026-06-26 | Schneider Eugene EVP, Chf Clinical Develop Ofcr | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −26,000 | 26,000 | ||
| 2026-06-26 | Monia Brett P Chief Executive Officer | Option exercise 10b5-1 | +50,000 | $56.78 | $2.8M | 295,571 |
| 2026-06-26 | Monia Brett P Chief Executive Officer | Sale 10b5-1 | −50,000 | $80.59 | $4.0M | 245,571 |
| 2026-06-26 | Monia Brett P Chief Executive Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −50,000 | 99,872 | ||
| 2026-06-25 | Monia Brett P Chief Executive Officer | Option exercise 10b5-1 | +21,072 | $32.60 | $687K | 266,643 |
| 2026-06-25 | Monia Brett P Chief Executive Officer | Sale 10b5-1 | −21,072 | $78.49 | $1.7M | 245,571 |
| 2026-06-25 | Monia Brett P Chief Executive Officer | Option exercise · Non-Qualified Stock Option (right to buy) 10b5-1 | −21,072 | 0 |
Page 3 of 18 · 360 trades